{"id":"NCT05343455","sponsor":"Journey Medical Corporation","briefTitle":"A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)","officialTitle":"A Multicenter, Randomized, Double-Blind, Parallel-Group, Active and Placebo Controlled Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Extended Release Capsules for the Treatment of Inflammatory Lesions of Rosacea Over 16 Weeks","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-03-29","primaryCompletion":"2023-06-30","completion":"2023-06-30","firstPosted":"2022-04-25","resultsPosted":"2024-12-03","lastUpdate":"2024-12-03"},"enrollment":330,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Papulopustular Rosacea"],"interventions":[{"type":"DRUG","name":"DFD-29","otherNames":[]},{"type":"DRUG","name":"Doxycycline","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"DFD-29","type":"EXPERIMENTAL"},{"label":"Doxycycline 40 mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a 16-week, multicenter, randomized, parallel-group, double-blind, controlled study. After assessing eligibility during a screening period of up to 30 days, approximately 320 subjects at least 18 years old who are diagnosed with moderate to severe papulopustular rosacea will be randomized in a 3:3:2 ratio to DFD-29 (40 mg), Doxycycline capsules 40 mg, or Placebo once daily for 16 weeks. Of the 320 subjects, approximately 160 subjects are planned to be enrolled at 15 sites in the US, while the remaining subjects are to be enrolled at 14 sites in the EU.","primaryOutcome":{"measure":"Investigator's Global Assessment (IGA) Treatment Success Compared to Placebo.","timeFrame":"Baseline to Week 16","effectByArm":[{"arm":"DFD-29","deltaMin":74,"sd":null},{"arm":"Placebo","deltaMin":22,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":24,"countries":["United States","Germany"]},"refs":{"pmids":["40042869"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":122},"commonTop":["Nasopharyngitis","COVID-19","Diarrhoea","Headache","Influenza"]}}